Eva Fortea Verdejo
Stock Analyst at Wells Fargo
(1.27)
# 1883
Out of 5,358 analysts
14
Total ratings
66.67%
Success rate
7.69%
Average return
Main Sectors:
Top Industries:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
ITOS ITeos Therapeutics | Downgrades: Equal-Weight | 13 12 | 10.19 | 17.76% | 6 | May 28, 2025 | |
BCAX Bicara Therapeutics | Upgrades: Equal-Weight | 8 8 | 11.48 | -30.31% | 2 | May 23, 2025 | |
MRUS Merus | Maintains: Overweight | 91 89 | 56.23 | 58.28% | 1 | May 8, 2025 | |
RCUS Arcus Biosciences | Maintains: Overweight | 29 26 | 9.96 | 161.04% | 2 | May 7, 2025 | |
XNCR Xencor | Maintains: Overweight | 37 33 | 9.65 | 241.97% | 2 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 34 | 30.22 | 12.51% | 1 | May 3, 2024 |